University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant

UMEM Educational Pearls

  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls
Previous  |  1 |  ... |  76 |  77 |  78 |  79 |  80 |  81 |  82 |  83 |  84 |  85 |  86 |  ... |  239 |  Next

Title: Why is the synthetic cannabinoid use making my patient bleed? - submitted by James Leonard

Category: Toxicology

Keywords: adulterated synthetic cannabinoid, elevated INR, brodifacoum (PubMed Search)

Posted: 4/4/2018 by Hong Kim, MD

In the past couple of weeks, there have been reports from Illinois about patients using adulterated synthetic cannabinoids, resulting in elevated INR and bleeding. To date, there are approximately 70 cases including 3 fatalities. Brodifacoum, a long-acting vitamin K mediated anticoagulant (similar to warfarin) has been identified in 10 cases. Brodifacoum is frequently used as rodenticide.

This week, Maryland Poison Center received our first notification of a patient with bleeding and elevated INR due to suspected adulterated synthetic cannabinoid use.

When evaluating our patient population:

  • Ask about synthetic cannabinoid use in patients with unexplained bleeding and elevated INR
  • Carefully examine patients with synthetic cannabinoid intoxication for any signs of bleeding, bruising or petechiae.  
     

Patient management of suspected cases:

  • ACTIVELY bleeding:
    • Fresh frozen plasma
    • Activated prothrombin complex concentrate (KCentra®) in life threatening bleeding.
    • Vitamin K 10 mg IV
    • *** Start oral vitamin K at 50 mg TID and titrate to goal INR < 2 ***
  • NOT bleeding and INR < 10: vitamin K 50 mg PO BID with titration if needed.
  • NOT bleeding and INR > 10: vitamin K 50 mg PO TID with titration if needed.

Patient can be discharged when INR < 2 is achieved with oral vitamine K regimen only (without recent FFP infusion).

Review of published cases highlights that most patients are started on a median doses of 100 mg/day (range: 15 - 600 mg) and stabilize on a PO regimen of 50-100 mg/day. Prolonged PO vitamin K course of 2 – 3 months or longer should be anticipated.

Pease call the Maryland Poison Center at 1-800-222-1222 as we are working with the Maryland Department of Health and CDC to track these cases. 

 

 

Show Additional Information

Show References

Gunja N, Coggins A, Bidny S. Management of intentional superwarfarin poisoning with long-term vitamin K and brodifacoum levels. Clinical Toxicology. 2011;49(5):385-390. doi:10.3109/15563650.2011.587126.

 



Title: Acute on Chronic Liver Failure

Category: Critical Care

Posted: 4/3/2018 by Mike Winters, MBA, MD

Acute on Chronic Liver Failure

  • Patients with cirrhosis can comprise up to 5% of an ICU population.
  • Many of these patients will present to the ED, and be admitted to the ICU, for acute on chronic liver failure.
  • A few management pearls for these patients include:
    • Consider albumin in patients with hepatorenal syndrome, large-volume paracentesis (> 5 L), and SBP
    • Norepinephrine is the initial vasopressor of choice; target a MAP ≥ 60 mm Hg
    • The INR does not accurately reflect bleeding in these patients.  Use platelet count and fibrinogen.
    • There is no need to correct coagulation abnormalities prior to routine procedures (e.g., central venous catheterization)

Show References

Fuhrmann V, Whitehouse T, Wendon J. The ten tips to manage critically ill patients with acute-on-chronic liver failure. Intensive Care Med. 2018.



Title: Do POLSTs Really Change What We Do? (Submitted by Dr Liz Clayborne)

Category: Geriatrics

Keywords: palliative, advance directive, end-of-life (PubMed Search)

Posted: 4/1/2018 by Danya Khoujah, MBBS (Updated: 9/17/2026)

25% of U.S. health care spending goes to the 6% of people who die every year. ICUs account for 20% of all health care costs. A new study has shown that patients with POLST (Physician Orders for Life-Sustaining Treatments) forms are less likely to receive unwanted life sustaining treatments when compared to patients with traditional Do-Not-Resuscitate orders (http://www.ohsu.edu/polst/). Using the POLST did not impact the degree of comfort care received for symptom management and helped individuals make more informed choices about the type and level of end-of-life care they wish to receive.

Show References

https://report.nih.gov/nihfactsheets/ViewFactSheet.aspx?csid=40
https://catalyst.nejm.org/value-icu-care-end-of-life/


Title: Timing Matters- Start Sepsis Treatment Early

Category: Critical Care

Keywords: sepsis (PubMed Search)

Posted: 3/31/2018 by Ashley Martinelli (Updated: 9/17/2026)

  • The current Surviving Sepsis Campaign Guidelines recommend treating septic patients with bundled care to improve outcomes. 
  • The first bundle should be completed within 3 hours of suspicion of sepsis and includes:
    • Obtain blood cultures before antibiotics
    • Obtain lactate level
    • Administer broad-spectrum antibiotics
    • Administer 30mL/kg crystalloid fluid for hypotension  (MAP <65, lactate >4)
  • A recent study in Critical Care Medicine examined the time frame when the delay of specific 3-hour bundle guideline recommendations applied to severe sepsis or septic shock becomes harmful and impacts mortality.
  • Retrospective cohort study of all adult patients hospitalized with severe sepsis or septic shock from January 2011 to July 31, 2015. Of the 5,072 patients enrolled, 95.8% received the 3-hour bundle.
  • Results:
    • Overall in-hospital mortality = 27.8%
    • If patient did not receive any of the 3-hr bundle items, in-house mortality = 41.1%
    • Statistically significant delays were linked to increased mortality for all bundle items
    • Delays beyond 3 hours were associated with minimal additional harm already caused by the 3-hour delay

Bottom Line: Implement sepsis protocols as soon as sepsis is suspected prior to the end of the 3 hour treatment window.

 

 

Show References

  1. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock,2012.Intensive Care Med 2013;39:165-228.
  2. Surviving Sepsis Campaign Executive Committee: Updated Bundles in Response to New Evidence. 2015.Available at: http://www.survivingsepsis.org/SiteCollectionDocuments/SSC_Bundle.pdf. Accessed Mar 31, 2018.
  3. Pruinelli L, Westra BL, Yadav P, et al. Delay within the 3-hour surviving sepsis campaign guidelines on mortality for patients with severe sepsis and septic shock. Crit Care Med. 2018;46:500-505.

 



Title: Mycoplasma pneumoniae Induced Rash and Mucositis (MIRM)

Category: Pediatrics

Posted: 3/30/2018 by Rose Chasm, MD (Updated: 9/17/2026)

  • Stevens-Johnsons like rash and mucositis
  • Most common in children and adolescents, with a mean age of 12 years old
  • More common in males than females, 2:1
  • Prodromal symptoms of cough, fever, and malaise precede
  • Mucositis far out of proportion to body rash, 90% vs 10%
  • Mucositis is primarily oral > ocular > genital in distribution, and can be severe
  • Body rash may involve palms and soles
  • Complications: dehydration, GIB, epiglottitis, blindness, pericardial effusion
  • Testing: PCR nasal wash/BAL; agglutination assays IgM/IgG
  • Treatment: azithromycin and supportive care; occasionally steroids; rarely IVIG
  • Unlike Stevens-Johnsons, prognosis is good.


Title: Atypical Stroke Symptoms

Category: Neurology

Keywords: stroke, altered mental status, gender, sex, confusion (PubMed Search)

Posted: 3/28/2018 by Danya Khoujah, MBBS (Updated: 9/17/2026)

Patients may present atypically with ischemic strokes, reporting symptoms such as face or hemibody pain, lightheadedness, mental status change, headache and non-neurological symptoms.

Up to 25% of patients will have these symptoms.

Women are more likely than men to present with these atypical (or “nontraditional”) symptoms, especially altered mental status.

Show References

Labiche LA, Chan W, Saldin KR, Morgenstern LB. Sex and acute stroke presentation. Ann Emerg Med. 2002;40(5):453-460.

Lisabeth LD, Brown DL, Hughes R, et al. Acute stroke symptoms: comparing women and men. Stroke. 2009;40(6):2031-2036.



Title: Avoid Hyperoxia Post-Cardiac Arrest!

Category: Critical Care

Keywords: cardiac arrest, OHCA, ROSC, targeted temperature management, oxygen, hyperoxia (PubMed Search)

Posted: 3/27/2018 by Kami Windsor, MD (Updated: 9/17/2026)

Background:

Animal studies in post-ROSC management after cardiac arrest have repeatedly demonstrated poorer neurological outcomes with higher amounts of oxygen administration.1 Studies in humans have also demonstrated dose-dependent associations between hyperoxia and poorer neurologic outcomes, as well as in-hospital mortality.2,3

Recent Data

A retrospective analysis of prospectively-collected data in 187 OHCA patients undergoing postarrest care with targeted temperature management found worse neurologic outcomes in patients experiencing hyperoxia in the first 6 hours following ROSC.4

This association was dose-dependent, with worsening outcomes as with higher PaO2 levels >200.

  • Adjusted OR 1.659 [95% CI, 1.194–2.305] at 200 mmHg
  • Adjusted OR 3.969 [95% CI, 1.450–10.862] for 300 mmHg
  • Trend towards worsening at 150 mmHg that did not reach statistical significance

Bottom Line:

  • Our initial management of these patients in the ED is crucial
  • In post-cardiac arrest patients, titrate immediate FiO2 to SpO2 ≥ 94% and PaO2 75 to 150/200 mmHg to avoid hyperoxia and worsening neurologic and survival outcomes. 

Show References

  1. Pilcher J, Weatherall M, Shirtcliffe P, et al. The effect of hyperoxia following cardiac arrest - a systematic review and meta-analysis of animal trials. Resuscitation. 2012;83(4):417-22. 
  2. Kilgannon JH, Jones AE, Parrillo JE, et al. Relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest. Circulation. 2011;123(23):2717-22.
  3. Janz DR, Hollenbeck RD, Pollock JS et al. Hyperoxia is associated with increased mortality in patients treated with mild therapeutic hypothermia after sudden cardiac arrest. Crit Care Med. 2012;40(12):3135-9. 
  4. Youn CS, Park KN, Kim SH, et al. The cumulative partial pressure of arterial oxygen is associated with neurological outcoems after cardiac arrest treated with targeted temperature management. Crit Care Med. 2018;46(4):e279-85.


Title: Boutonniere Deformity aka buttonhole deformity

Category: Orthopedics

Keywords: Hand injury (PubMed Search)

Posted: 3/24/2018 by Brian Corwell, MD (Updated: 9/17/2026)

Boutonniere Deformity
aka buttonhole deformity

Misdiagnosed as a “jammed” or “sprained” finger

  • Deformity occurs at the PIP joint
  • Trauma to the PIP joint can cause the joint capsule to tear, the head of the phalanx can buttonhole thru the defect and the lateral bands of the extensor tendons fall laterally & contract
  • The lateral bands then function as PIP flexors and not extensors
  • DIP hyperextension due to excessive pull of the displaced lateral bands
  • As a result, the pateint WILL be able to flex the DIP joint, but WILL NOT be able to extend   the PIP joint                                                                    
  • OCCURS 1 - 3 weeks post injury
  • May not present with classic textbook deformity
  • The Elson test is the best way to detect the injury pattern before the deformity is evident
  • https://www.youtube.com/watch?v=G9HY0qXWUvE

 

 

 



Title: The Russian connection 2.0 -- Sergei Skripal

Category: Toxicology

Keywords: nerve agents, organophosphate compounds (PubMed Search)

Posted: 3/21/2018 by Hong Kim, MD (Updated: 3/21/2018)

Recently, an ex-Russian spy and his daughter were poisoned in Salisbury, England using a Soviet nerve agent called Novichok. He joins a list of defectors and ex-spies who's poisoning have been connected to Russia.

Nerve agents are organophosphate compounds, similar to the commercially available pesticides, but significantly more potent. Nerve agents such as VX take seconds to minutes to irreversibly inhibit acetylcholinesterase by “aging” and result in clinical toxicity. 

Signs and symptoms

  • Muscarinic: DUMBELS or SLUDGE and Killer B's
  • Nicotinic: muscle weakness & paralysis

Treatment

  • Decontamination
  • Atropine – 2 mg IV and double the dose every 3 – 5 minutes until clearing of bronchorrhea, bronchospasm and bradycardia
  • Pralidoxime – reverses inhibition of acetylcholinesterases that are not aged


Title: Management of Refractory Hypoxemia During VV ECMO

Category: Critical Care

Posted: 3/21/2018 by Ashley Menne, MD

Worsening hypoxemia is not uncommon upon initiation of VV ECMO for severe ARDS as tidal volumes drop to double digits  (often <20cc) after transition to “lung rest” ventilator settings. The following are strategies to improve peripheral oxygenation:

 

1. Increase the blood’s oxygen content

-       Ensure FIO2 of ECMO sweep gas is 1

-       Increase ECMO blood flow

o   Limited by cannula size and configuration – may require placement of additional venous drainage cannula

o   Also limited by greater risk of recirculation and hemolysis

-       Increase blood oxygen-carrying capacity

o   Transfuse PRBCs – some advocate for goal hemoglobin 12-14, though institutional practices vary significantly

 

2. Minimize recirculation

-       Maximize distance between drainage and return cannulae

 

3. Reduce oxygen consumption

-       Optimize sedation and neuromuscular blockade. (This is not the appropriate scenario for awake ECMO.)

-       Consider therapeutic hypothermia

 

4. Decrease cardiac output and intrapulmonary shunt

-       Consider beta blocker (esmolol) infusion

-       Prone positioning (only if staff are experienced with proning on ECMO as this poses significant risk of cannula displacement)

 

5. Consider switching to hybrid configuration (VVA – continued venous drainage cannula and venous return cannula with addition of arterial return cannula)  

Show References

Montisci A, Maj G, Zangrillo A, Winterton D, Pappalardo F. Management of Refractory Hypoxemia During Venovenous Extracorporeal Membrane Oxygenation for ARDS. ASAIO J. 2015;61(3):227-236. doi:10.1097/MAT.0000000000000207.



Title: Risk Factors for Peri-Intubation Cardiac Arrest

Category: Critical Care

Posted: 3/20/2018 by Mike Winters, MBA, MD

Peri-Intubation Cardiac Arrest

  • Endotracheal intubation is a high-risk procedure, especially in the critically ill patient.
  • The incidence of peri-intubation cardiac arrest ranges from 2% to 5%, and is associated with significant increases in morbidity and mortality.
  • Authors of a recent retrospective analysis across 64 French ICUs sought to determine risk factors for cardiac arrest during ICU intubation.
  • Among 1,847 intubations, the main predictors of cardiac arrest during intubation were:
    • Pre-intubation arterial hypotension (SBP < 90 mm Hg) (OR 3.4)
    • Pre-intubation hypoxemia (OR 3.99)
    • Absence of preoxygenation (OR 3.58)
    • Obesity (OR 2)
    • Age > 75 years of age (OR 2.25)
  • Take Home Point
    • Pay close attention to these risk factors and "resuscitate before you intubate".

Show References

De Jong A, et al. Cardiac arrest and mortality related to intubation procedure in critically ill adult patients: A multicenter cohort study. Crit Care Med. 2018; 46:532-9.



Title: Is a fluid bolus needed in a pediatric asthma exacerbation?

Category: Pediatrics

Keywords: Asthma, pediatrics, fluid (PubMed Search)

Posted: 3/16/2018 by Jenny Guyther, MD

Fluid overload (defined in this study as (fluid input-output)/weight)) is associated with longer hospital stays, longer treatment duration and oxygen use.

Bottom line: Treat dehydration appropriately but try not to over resuscitate the asthmatic.  Further studies are needed before definitive recommendations are made.

 

Show Additional Information

This was a retrospective cohort study over 7 years at a single children’s hospital.  Children included were older than 6 years and were admitted with no pneumonia or history of chronic lung disease.  Fluid intake and output were collected for the initial 72 hours of hospitalization or discharge.  The study included 1175 encounters.  On average, 1% increase in fluid overload was associated with about a 7 hour increase in hospital stay, 6 hours longer of beta agonist and 2 hours longer of supplemental oxygen.  Fluid overload of more than 7% was determined to be clinically meaningful showing an increased risk of requiring supplemental oxygen and non-invasive pressure ventilation.  One of the limitations of this study that the authors mention is that the weight they used is the admission weight and the patient may already be dehydrated, thereby overestimating fluid overload.

Show References

Kantor et al.  Fluid balance is Associated with Clinical Outcomes and Extravascular Lung Water in Children with Acute Asthma Exacerbation.  American Journal of Respiratory and Critical Care Medicine.  Epub ahead of print, Jan 9, 2018.



Title: Prehospital Stroke Scales for Large Vessel Occlusion

Category: Neurology

Keywords: stroke, prehospital, large vessel occlusion, NIHSS, RACE, LAMS, VAN (PubMed Search)

Posted: 3/14/2018 by WanTsu Wendy Chang, MD (Updated: 9/17/2026)

  • A recent systematic review evaluated the diagnostic accuracy of 19 prehospital stroke scales.
  • Arm motor strength is the most frequently evaluated item by the scales (15/19), followed by gaze (13/19) and language (13/19).
  • Only 4 scales (RACE, LAMS, VAN, sNIHSS-EMS) were performed by paramedics in their original studies.
  • The NIHSS, LAMS, and VAN appear to have better results in predicting large vessel occlusion.
  • The presence of hemineglect, a sign of cortical involvement, improved the accuracy of the scale.

Show Additional Information

  • There is growing evidence for mechanical thrombectomy in acute ischemic stroke patients with large vessel occlusion.
  • Identification of potential eligible patients begin in the prehospital setting in order for preferential transport of these patients to comprehensive stroke centers.
  • Selected prehospital stroke scales:
    • RACE = Rapid Arterial Occlusion Evaluation Scale
    • LAMS = Los Angeles Motor Scale
    • VAN = Stroke Vision, Aphasia, Neglect Assessment
    • NIHSS = National Institute of Health Stroke Scale

Show References

 
  • Vidale S, Agostini E. Prehospital stroke scales and large vessel occlusion: A systematic review. Acta Neurol Scand. 2018 Feb 11. [Epub ahead of print]

Follow me on Twitter @EM_NCC



Title: Pectoralis Major Rupture

Category: Orthopedics

Keywords: Shoulder pain, muscle injury (PubMed Search)

Posted: 3/10/2018 by Brian Corwell, MD (Updated: 9/17/2026)

Pectoralis Major Rupture

 

Most commonly seen in male weightlifters

Usually occurs as a tendon avulsion

Incidence is increasing

Hx: Sudden, sharp, tearing sensation with pain and weakness with arm movement

PE: Palpable defect and deformity of anterior axillary fold. Bruising and swelling.

               Deformity may not be obvious with arm by side and relaxed

Testing: Weakness with ADDuction and internal rotation

https://lh3.googleusercontent.com/wQcuu_sG76t_DLWocO_c2344IT69g_vWXY0FKtqhR4L37qrrsIuW607LZkVFT8QTLAdaTeU=s170

 

Treatment:  Operative treatment has better outcomes but depends on patient subgroups

Nonoperative treatment generally indicated for partial ruptures and tears in the body of the pec and muscle tendon junction

               Sling, ice and pain control.

Operative treatment generally for high demand patients (athletes) and bony avulsion injuries

 



Title: Can you smell the bitter almond odor in your ER?

Category: Toxicology

Keywords: cyanide, signs and symptoms (PubMed Search)

Posted: 3/8/2018 by Hong Kim, MD

Signs and symptoms of acute cyanide poisoning are not well characterized due to its rare occurrence.  Commonly mentioned characteristics of bitter almond odor and cherry red skin have poor clinical utility.

Recently published review of 65 articles (102 patients) showed that most patients experienced following signs and symptoms:

  1. Unresponsive: 78%
  2. Respiratory failure: 73%
  3. Hypotension: 54%
  4. Cardiac arrest: 20%
  5. Seizure: 20%
  6. Cyanosis: 15%
  7. Odor: 15%
  8. Cherry red skin: 11%

There is no clear toxidrome for cyanide poisoning.

In a poisoned patient, health care providers should consider cyanide in their differential diagnosis in the presence of severe metabolic and lactic acidosis (lactic acid > 8 in isolated cyanide poisoning or > 10 in smoke/fire victim).

Show References

Parker-Cote JL et al. Challenges in the diagnosis of acute cyanide poisoning. Clin Toxicol 2018 Feb 8:1-9. doi: 10.1080/15563650.2018.1435886. [Epub ahead of print]



Title: Bruising in the Geriatric Population (Submitted by Dr. M. Chris Jackson)

Category: Geriatrics

Keywords: bruising, elderly, forensic, abuse (PubMed Search)

Posted: 3/4/2018 by Danya Khoujah, MBBS

Contrary to a popularly held belief that one can estimate the age of a bruise by its color, present day research found that the color of a bruise at the time of its initial appearance is unpredictable. It is also affected by medications.
Take Home: Do not assumptions about the age of the bruise based on the color.

Show References

1. Mosqueda, L., K. Burnight, and S. Liao, Bruising in the Geriatric Population, final report
submitted to the National Institute of Justice, Washington, DC: June 2006 (NCJ 214649),
available at www.ncjrs.gov/pdffiles1/nij/grants/214649.pdf.
2. Ralph J. Riviello, MD, MS, FACEP | on February 6, 2014 Can You Tell How Old This Bruise Is
Based on its Color? ACEP Now: Vol 37 – No 02 – February 2018
3. NIJ Journal Issue No. 255: Elder Abuse in the United StatesCurrently selected Elder Abuse in
the United States, Catherine C. McNamee with Mary B. Murphy


Title: Fosfomycin for UTIs

Category: Pharmacology & Therapeutics

Keywords: Fosfomycin, urinary tract infection, cystitis (PubMed Search)

Posted: 3/3/2018 by Wesley Oliver

Fosfomycin is an antibiotic infrequently used for the treatment of urinary tract infections (UTIs). It has a broad spectrum of activity that covers both gram-positive (MRSA, VRE) and gram-negative bacteria (Pseudomonas, ESBL, and carbapenem-resistant Enterobacteriaceae), which is useful in the treatment of multidrug-resistant bacteria. 

Fosfomycin is FDA approved for the treatment of uncomplicated UTIs in women due to susceptible strains of Escherichia coli and Enterococcus faecalis (3g oral as a single dose). Data has also demonstrated that it can be used for complicated UTIs; however, dosing is different in this population (3 g oral every 2-3 days for 3 doses).  Fosfomycin is not recommended for pyelonephritis.

The broad spectrum of activity, in addition to only needing a single dose in most cases, makes fosfomycin an attractive option; however, it should be reserved for use in certain circumstances.  Fosfomycin should not be considered as a first-line option.  It is also more expensive than other medications (~$100/dose) and in countries with high rates of utilization bacteria are developing resistance to fosfomycin.  In addition, most outpatient pharmacies do not keep this medication in stock.

Take-Home Point:

Fosfomycin should be reserved for multidrug-resistant UTIs in which other first-line options have been exhausted.

Show References

  1. Gupta K, Hooton TM, Naber KG, et al; Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5): e103-e120. doi: 10.1093/cid/ciq257.

  2. Michalopoulos AS, Livaditis IG, Gougoutas V. The revival of fosfomycin. Int J Infect Dis. 2011;15(11):e732-e739. doi: 10.1016/j.ijid.2011.07.007.

  3. MONUROL [prescribing information]. St. Louis, MO: Forest Pharmaceuticals, Inc; 2007. www.accessdata.fda.gov/drugsatfda_docs/label/2008/050717s005lbl.pdf. Accessed 9/7/2017September 7, 2017.

  4. Oteo J, Bautista V, Lara N, et al; Spanish ESBL-EARS-Net Study Group. Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. J Antimicrob Chemother. 2010;65(11):2459-2463. doi: 10.1093/jac/dkq346.

  5. Raz R. Fosfomycin: an old—new antibiotic. Clin Microbiol Infect. 2012;18(1): 4-7. doi: 10.1111/j.1469-0691.2011.03636.x

  6. Reffert JL, Smith WJ. Fosfomycin for the treatment of resistant gram-negative bacterial infections. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2014;34(8):845-857. doi: 10.1002/phar.1434.

  7. Vardakas KZ, Legakis NJ, Triarides N, Falagas ME. Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature. Int J Antimicrob Agents. 2016;47(4):269-285. doi: 10.1016/j.ijantimicag.2016.02.001.

  8. Wankum, Michael, et al. “Fosfomycin Use.” Pharmacy Times, 30 Nov. 2017, www.pharmacytimes.com/publications/health-system-edition/2017/november2017/fosfomycin-use.

 



Title: Clinical Predictors of Cardiovascular Toxicity in Drug Overdose

Category: Toxicology

Keywords: QTc, Dysrhythmias, drug overdose (PubMed Search)

Posted: 3/1/2018 by Kathy Prybys, DO

A leading cause of cardiac arrest in patients 40 years and younger is due to drug poisoning.  Adverse cardiovascular events (ACVE) such as myocardial injury (by biomarker or ECG), shock (hypotension or hypoperfusion requiring vasopressors), ventricular dysrhythmias (ventricular tachycardia/fibrillation, torsade de pointes), and cardiac arrest (loss of pulse requiring CPR) are responsible for the largest proportion of morbidity and mortality overdose emergencies. Clinical predictors of adverse cardiovascular events in drug overdose in recent studies include:

  • QTc prolongation on presentation ECG ( > 500 msec )
  • Prior history of either coronary artery disease or congestive heart failure
  • Metabolic acidosis (elevated serum lactate)

 

Bottom line:

Obtain ECG and perform continuous telemetry monitoring in overdose patients with above risk factors. Patients with two or more risk factors have extremely high risk of in-hospital adverse cardiovascular events and intensive care setting should be considered.

 

 

Show References

Clinical risk factors for in-hospital adverse cardiovascular events after acute drug overdose. Manini AF, Hoffman RS, et al. Acad Emerg Med. 2015:22(5):499-507.

Incidence of adverse cardiovascular events in adults following drug overdose.  Manini AF, Nelson LS, et al. Acad Emerg Med. 2012;19:843–9.



Title: Headache in the Bodybuilder

Category: Neurology

Keywords: headache, steroids, bleed (PubMed Search)

Posted: 2/28/2018 by Danya Khoujah, MBBS

Benign headaches are common in bodybuilders. However, several less benign headaches are worth noting:

  • Low cerebrospinal fluid (CSF) pressure headache: caused by a small dural tear mostly at the thoracic level. Similar to postdural headache. Treated by recumbency, and blood patches if recalcitrant.
  • Subarachnoid hemorrhage (SAH)
  • Spontaneous intracranial hemorrhage
  • Ischemic stroke
  • Dural sinus thrombosis

All except the first two are exclusively reported in patients on anabolic steroids, growth hormone, and/or “energy” supplements. Make sure to ask your patient about these risk factors.

 

Show References

Busche K. Neurologic Disorders Associated with Weight lifting and Bodybuilding. Neurology Clinics. 26 (2008) 309–324



Title: Empiric Antifungal Therapy in Septic Shock

Category: Critical Care

Keywords: ICU, fungal infection, septic shock, antifungal therapy, empiric (PubMed Search)

Posted: 2/27/2018 by Kami Windsor, MD

Which septic patients should receive empiric antifungal therapy?

Patients with fungemia only make up about 5% of patients presenting with septic shock, but invasive fungal infections are associated with increased hospital mortality (40-50%), prolonged ICU and hospital length of stay, and increased costs of care.1

The EMPIRICUS trial showed no mortality benefit to empiric antifungals for all, even patients with candidal colonization and recent exposure to antibiotics.2

Bottom Line

Therapy should always be tailored to the specific patient, but providers should strongly consider admininistering empiric echinocandin (micafungin, caspofungin) over fluconazole in patients with severe sepsis/septic shock and:

  • Immunosuppression (chronic steroids, neutropenia, organ transplant)
  • Prolonged central venous catheters
  • TPN
  • Yeast colonization
  • Severe pancreatitis
  • Recent abdominal surgeries or procedures (perforation repairs, resections, etc.) or concern for impaired gut integrity

*Especially consider addition of antifungal in patients who do not show improvements after initial management with IVF and broad spectrum antibiotics in the ED.*

Show Additional Information

Which septic patients should receive empiric antifungal therapy?

Patients with fungemia only make up about 5% of patients presenting with septic shock, but invasive fungal infections are associated with increased hospital mortality (40-50%), prolonged ICU and hospital length of stay, and increased costs of care.1

The EMPIRICUS trial showed no mortality benefit to empiric antifungals for all, even patients with candidal colonization and recent exposure to antibiotics. (It demonstrated decreased rate of new invasive fungal infection, but did not increase survival).2

Risk factors for invasive fungal infections include:3

  • Immunosuppresion
  • Prolonged central venous catheter
  • Total parenteral nutrition (TPN)
  • Renal failure/dialysis
  • Recent broad spectrum antibiotics
  • Yeast colonization (as noted by previous urine or bronch cultures)
  • Recent abdominal surgery (especially with disruption of intestinal wall)
  • Severe pancreatitis

Which antifungal agent should we use?

Although older studies have not shown benefits to echinocandin, such as micafungin, over fluconazole as initial empiric antifungal therapy,4,5 a recent study by Garnacho-Montero et al. demonstrated improved 30 and 90-day mortality in patients with candidemia whose initial antibiotic was an echinocandin rather than fluconazole.6  

Show References

  1. Xie GH, Xiang-Ming F, Qiang F, et al. Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients.
  2. Timsit JF, Azoulay E, Schwebel C, et al. Empirical micafungin treatment and survival without invavsive fungal infection in adults with ICU-aquired sepsis, candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial. JAMA 2016;316(15): 1555-64.
  3. Muskett H, Shahin J, Eyres G, et al. Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit Care 2011;15(6): R287.
  4. Murri R, Scoppettuolo G, Ventura G, et al. Initial antifungal strategy does not correlate with mortality in patients with candidemia. Eur J Clin Microbiol Infect Dis 2016; 35:187–93.
  5. López-Cortés LE, Almirante B, Cuenca-Estrella M, et al. Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: A propensity score-derived analysis of a population-based, multicentre prospective cohort. Clin Microbiol Infect 2016; 22:733.e1–733.e8
  6. Garnacho-Montero J, Díaz-Martín A, Cantó-Bulnes L, et al. Initial antifungal strategy reduces mortality in critically ill patients with candidemia: a propensity score-adjusted analysis of a multicenter study.  Crit Care Med 2018;46(3): 384-93.


Previous  |  1 |  ... |  76 |  77 |  78 |  79 |  80 |  81 |  82 |  83 |  84 |  85 |  86 |  ... |  239 |  Next
University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map